Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec Compensation
confidence 95%
filed 2026-06-08
Item 5.02
The filing discloses approval by the Compensation Committee of performance-based restricted stock unit (PBRSU) awards for fiscal year 2027 to named executive officers, including CEO Robert Bruggeworth and CFO Grant Brown, along with a specific retention award to Philip Chesley. These are compensatory arrangements subject to performance and service conditions, directly falling under Item 5.02(e) disclosure requirements. The disclosure includes target grant values, performance metrics, and vesting conditions—all hallmarks of executive compensation arrangements material to investor assessment.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
Item 8.01
The disclosure announces a proposed sale of multifamily loans acquired through OceanFirst's recently completed acquisition of Flushing Financial Corporation. While the sale itself could constitute a disposition (ma_activity), the filing emphasizes it as a proposed action tied to post-acquisition portfolio management rather than a completed material transaction. The language "proposed sale" and the context of managing acquired assets suggests this is a material portfolio action that does not cleanly fit the more specific M&A categories, warranting classification as other_material.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-08
Item 8.01
The filing discloses completion of the Kito Crosby Acquisition on February 3, 2026, pursuant to a Stock Purchase Agreement dated February 10, 2025. Although Item 8.01 is used here to provide historical financial statements of the acquired company, the core event is the material acquisition of Kito Crosby Limited by Columbus McKinnon Corporation, which is a change-of-control transaction material to investors.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-06-08
Item 4.01
This is a clear auditor change: Assure CPA, LLC resigned as the independent registered public accounting firm on June 3, 2026, following its merger into Sadler Gibb & Associates LLC, and Sadler Gibb & Associates LLC was engaged as the new auditor on June 4, 2026. The disclosure is made under Item 4.01 (Changes in Registrant's Certifying Accountant), the standard Item for auditor changes. While the prior auditor's reports contained an explanatory paragraph on going concern, the primary event disclosed is the auditor transition itself, which is material to investors' assessment of financial reporting oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-08
Item 5.02
Alan Chang was appointed to the Board of Directors of Tradewinds Universal on June 5, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
Item 5.03
Shareholders approved an amendment to the Articles of Incorporation increasing authorized common shares from 75 million to 250 million shares, a 233% increase that signals potential future capital-raising or dilution.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-08
Item 5.02
Adrian Goldfarb has been appointed Interim Chief Financial Officer effective June 8, 2026, following Leah Brown's departure from the CFO role to resume her position as Senior Vice President of Accounting. While the filing discloses both a departure and an appointment, the principal disclosed action centers on Goldfarb's appointment to the CFO role, a material executive position. The appointment of an interim CFO is material to investors as it signals a change in financial leadership and indicates the company is conducting a search for a permanent replacement.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-08
Item 4.01
This is a clear auditor change under Item 4.01. Assure CPA, LLC resigned effective June 3, 2026, as a result of being acquired by and combining its practice with Sadler Gibb & Associates, LLC, which was then engaged as the new independent registered public accounting firm effective June 5, 2026. The filing explicitly discloses both the dismissal/resignation of the previous auditor and the engagement of the new auditor, with no disagreements or reportable events noted.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 8.01
The filing discloses postponement of a special stockholder meeting scheduled to vote on a proposed transaction with CrossCountry Intermediate Holdco, LLC. While the postponement itself is administrative, the underlying transaction is material M&A activity. However, since the Item 8.01 disclosure focuses on the procedural postponement rather than the transaction terms or status, and no dedicated M&A Item (1.01, 2.01, 5.01) is cited, this is best classified as other_material—a material event that does not fit the more specific M&A categories, as the core disclosure is the meeting delay rather than transaction substance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-08
Item 2.02
FuelCell Energy Inc. disclosed financial results for the three and six months ended April 30, 2026, via a press release furnished as Exhibit 99.1, providing a business update and operational performance metrics material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-08
Item 1.01
Standard BioTools entered into a definitive Merger Agreement with Treeline Biosciences on June 6, 2026, in an all-stock transaction valuing Treeline at $2.5 billion and Standard BioTools at $460 million, with Standard BioTools stockholders expected to hold approximately 16% of the combined company post-closing. The transaction constitutes a material change of control requiring stockholder approval and SEC registration.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-08
Item 3.02
Standard BioTools will issue unregistered Common Stock in connection with the Merger Agreement, relying on Section 4(a)(2) and Regulation D exemptions. This equity issuance materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 93%
filed 2026-06-08
Item 1.01
Alliance Resource Partners entered into definitive agreements on June 5, 2026 to acquire all general partner and limited partner interests in AllDale Minerals III and IV for approximately $206.2 million, funded through cash on hand and new/existing credit facilities. This represents a material expansion of the Partnership's mineral interests portfolio.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 8.01
MetaVia disclosed presentation of new Phase 1 clinical data for its lead obesity and metabolic disease candidates (DA-1726 and DA-1241) and preclinical combination data for vanoglipel at the ADA 2026 Scientific Sessions, showing statistically significant body weight reductions (6.1–9.1%) and favorable safety profiles. These positive interim clinical and preclinical results would materially affect investor assessment of the company's drug development trajectory and competitive position in the obesity/metabolic disease space.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-08
Item 1.01
Porsche Auto Funding LLC entered into a material definitive agreement for the issuance of $911 million in asset-backed notes by Porsche Innovative Lease Owner Trust 2026-1, with an underwriting agreement executed on June 4, 2026. The transaction involves creation of a separate unit of beneficial interest and allocation of retail vehicle leases to securitize the asset pool, constituting a material financing/securitization transaction affecting the registrant's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 8.01
This disclosure concerns the issuance of $911 million in aggregate principal amount of asset-backed notes by a special-purpose trust, with filing required to satisfy undertakings for legality and tax opinions. While the issuance itself is material to investors in the notes, it does not fit cleanly into the standard taxonomy categories (not a traditional M&A activity, not a restatement, not an impairment). The 8-K is filed to document the closing of a securitization transaction and deliver required legal opinions, making this a material event that falls outside more specific categories.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-08
Item 3.02
Brookfield Private Equity Fund LP sold approximately $8.085 million in unregistered limited partnership units (Class S and Class I) on May 1, 2026, pursuant to a continuous private offering exempt under Section 4(a)(2) and Regulation D, diluting existing unit holders' ownership interests.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-08
Item 2.01
The filing discloses completion of a disposition of 24 single-family residential units from the Ballast portfolio for approximately $8.5 million in aggregate sales price and $7.8 million in net proceeds. This constitutes a material disposition of assets under Item 2.01, representing a significant reduction in the Company's real estate holdings and generating material cash proceeds.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
MetaVia held its Annual Meeting of Stockholders on June 8, 2026, with shareholders voting on five proposals: election of Class I directors, ratification of auditors, approval of a reverse stock split, amendment to the 2022 Equity Incentive Plan increasing available shares by 200,000, and adjournment authority. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of Capricor's Annual Meeting of stockholders held on June 4, 2026. The filing presents detailed voting tallies for all five proposals, including election of eight directors, ratification of auditors, advisory votes on executive compensation and frequency, and a failed amendment to the Certificate of Incorporation. Shareholder vote results are material to investors as they determine board composition and governance matters.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-08
Item 8.01
The filing discloses an all-stock merger-of-equals transaction between AvalonBay Communities and Equity Residential, previously announced on May 20, 2026, with a joint press release on June 8, 2026 announcing the combined company's executive leadership team. This is a material acquisition/change of control event that would substantially affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Jefferson Capital's Annual Meeting of Stockholders held on June 5, 2026. The filing presents voting tallies for two proposals: election of three Class I directors (David Burton, Thomas Harding, and Thomas Lydon, Jr.) and ratification of Deloitte & Touche LLP as independent auditor. All proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm board composition and auditor appointment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-08
Item 8.01
The filing discloses the closing of a series of local asset purchase agreements whereby Senseonics acquired Ascensia's Eversense CGM commercial assets in four European countries (Italy, Germany, Spain, and Sweden). The closings occurred on June 1-8, 2026, following satisfaction of customary closing conditions. This constitutes completion of a material acquisition of assets and represents a significant M&A transaction requiring 8-K disclosure under Item 1.01/2.01.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 7.01
The disclosure announces the redemption deadline for FGMC's public stockholders in connection with the business combination with BOXABL Inc. While the redemption deadline itself is a procedural milestone, it is material to investors as it represents a critical juncture in the SPAC merger process that affects shareholder rights and the capital structure of the combined entity. This does not fit neatly into the M&A activity category (which typically covers entry, completion, or termination of the transaction itself) but rather represents a material procedural event within an ongoing M&A transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Innodata's Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes for four proposals: election of five directors, ratification of BDO India Services as independent auditors, advisory approval of named executive officer compensation, and approval of the Amended and Restated Equity Compensation Plan. All proposals passed with substantial majorities, making this a material governance event that investors rely upon to assess board composition and executive accountability.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 8.01
Liquidia Corporation announced its addition to the S&P SmallCap 600® Index effective June 22, 2026. Index inclusion is a material corporate event that typically increases visibility, liquidity, and institutional investor interest in the stock, affecting the total mix of information available to investors. While not fitting neatly into the standard taxonomy categories, this disclosure warrants classification as a material event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-08
Item 1.01
This Item 1.01 discloses entry into an amended and restated business combination agreement between Spring Valley Acquisition Corp. III (SPAC) and General Fusion Inc., with the second amendment executed on June 3, 2026. The filing describes a material acquisition/merger transaction involving SPAC continuation, amalgamation of NewCo with the SPAC, and change of control, which are quintessential M&A activities under Item 1.01.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 1.01
FS KKR Capital Corp entered into a Sixteenth Supplemental Indenture on June 8, 2026 to issue $900 million in 7.500% notes due 2031, generating approximately $890 million in net proceeds. This represents a significant debt issuance and capital raise that materially increases the company's debt obligations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-08
Item 5.02
The filing discloses the election of Mark A. Edmunds as a director and his appointment as Chair of the Audit and Finance Committee and member of the Cyber and Technology Oversight Committee, effective immediately on June 8, 2026. While the section also includes Silvia Davila's resignation, the principal disclosed action centers on the appointment of a new director to key committee roles. Director appointments to significant committee positions are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Alarm.com's June 3, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of eight directors, ratification of PricewaterhouseCoopers LLP as auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely on to assess board composition and management accountability.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-08
Item 5.02
William Reinhardt's retirement from the Board of Metropolitan Bank Holding Corp. and its subsidiary Metropolitan Commercial Bank, effective immediately on June 6, 2026, constitutes a departure of a director. While the disclosure also mentions his honorary designation as director emeritus, the principal disclosed action is his departure from the board, which is material to investors assessing the composition and governance of the registrant.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-08
Item 3.02
Elite Express completed a private placement of 32,000,000 shares of Class A Common Stock at $0.25 per share for $8,000,000 in gross proceeds on June 4, 2026, conducted offshore under Regulation S to non-U.S. investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-08
Item 5.02
Ye Hua was appointed as Chief Financial Officer effective June 8, 2026, bringing CPA credentials, a Master's in Accountancy, and prior tax and accounting experience to the role.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-08
Item 5.02
The filing discloses amended and restated employment agreements for three named executives (William Santana Li, Apoorv S. Dwivedi, and Mercedes Soria) that establish new base salaries, annual bonus targets, performance-based cash awards with aggregate target values of $65M, $35.75M, and $22.75M respectively, severance arrangements, and stock option grants. This is a comprehensive compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure, and materially affects investor assessment of executive incentives and potential future obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-08
Item 2.02
The filing explicitly discloses that on June 8, 2026, Motorcar Parts of America issued a press release announcing earnings for the fiscal quarter and year ended March 31, 2026, with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, and earnings announcements are material to investors' assessment of the company's financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-08
Item 7.01
The filing discloses an Agreement and Plan of Merger entered into on May 2, 2026, whereby Global Business Travel Group is to be acquired by Long Lake Management through Parent and Gaia Merger Sub. The June 8, 2026 disclosure provides financial metrics to prospective lenders in connection with the debt financing for this transaction. This is a material acquisition/change of control event, even though disclosed under Item 7.01 (Regulation FD Disclosure) rather than the more typical Item 1.01 or 2.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-08
Item 1.01
While Item 1.01 formally covers the Settlement Agreement with Helena, the disclosure's material substance centers on the proposed three-way business combination among DevvStream, XCF Global, and Southern Energy Renewables. The settlement itself—resolving a $10M convertible note dispute—is material, but the filing's extensive discussion of merger consent, Section 13 waiver survival, and repeated references to the "proposed business combination transaction" indicate that the M&A activity (the merger) is the primary material event driving this disclosure. The settlement is largely a prerequisite to clearing the path for the merger to proceed.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-08
Item 5.02
Ludwig N. Hantson was appointed to the Board of Directors of Ionis Pharmaceuticals effective June 4, 2026. Hantson brings 30+ years of biopharmaceutical leadership experience, including prior CEO roles at Alexion and Baxalta.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Ionis Pharmaceuticals held its Annual Meeting of Stockholders on June 4, 2026, with voting results disclosed for five proposals: director elections (Berthelsen and Herman), advisory compensation vote, equity plan amendment (9.5M shares), employee stock purchase plan amendment, and auditor ratification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-08
Item 5.02
The filing discloses the appointment of Tim Nauss as a Class II director of CarParts.com, Inc., effective immediately, to serve until the 2029 Annual Meeting. The Board increased its size to seven directors to accommodate this appointment. While the disclosure mentions standard director compensation ($50,000 annual retainer), the principal action is the appointment itself, not a compensation arrangement. This is material as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-08
Item 5.02
Stanley J. Sutula III was appointed as a director effective June 4, 2026, expanding the Board from eleven to twelve members and joining the Audit Committee. Director Cara Heiden retired concurrently. The appointment represents a material change to board composition and committee oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 disclosure reports the results of AtaiBeckley Inc.'s annual meeting of stockholders held on June 4, 2026, including voting outcomes for the election of three Class I directors (Sabrina Martucci Johnson, Amir Kalali, M.D., and Andrea Heslin Smiley) and ratification of Deloitte & Touche LLP as independent auditor. The filing explicitly states all three nominees were elected and Proposal 2 was approved, making this a standard shareholder vote results disclosure that is material to investors' understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-08
Item 5.02
The filing discloses two executive events: the retirement of Jill Livesay (Vice President, Controller and Principal Accounting Officer) effective July 31, 2026, and the appointment of Enrique N. Mayor-Mora as Principal Accounting Officer effective upon Livesay's retirement. While both a departure and appointment occur, the principal disclosed action centers on the appointment of Mayor-Mora to the PAO role, with detailed background on his 15-year tenure and career progression at CarMax. The appointment of a principal accounting officer is material to investors as it affects financial reporting oversight and internal controls.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-08
The filing discloses unregistered sales of convertible promissory notes totaling $225,000 in principal (with $247,500 repayment obligation) under Item 3.02. The 2026 Bridge Notes are convertible into common stock at $0.15 per share and were sold pursuant to Section 4(a)(2) and Regulation D exemptions. Additionally, Item 8.01 describes a non-binding term sheet for a $30 million Equity Line of Credit (ELOC) facility with registration planned via Form S-1, indicating substantial dilutive equity issuance activity. This is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
The filing discloses an amendment to extend IGC Pharma's Master Loan and Security Agreement with O-Bank Co., Ltd., increasing the facility fee from $48,000 to $60,000 while maintaining a $12,000,000 maximum aggregate limit. While Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of Direct Financial Obligation) are cited, this is a routine extension of an existing credit facility rather than a new material acquisition, debt covenant breach, or other specifically-defined event type. The modest fee increase and continuation of substantially unchanged terms suggest administrative renewal rather than a transformative financial event, though the extension of material debt facilities warrants disclosure as material to investors.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 8.01
The Board formed a Transformation Committee on June 5, 2026, to oversee a company-wide transformation initiative focused on business positioning, cost structure optimization, growth opportunities, capital allocation, and portfolio composition. While the disclosure does not fit neatly into standard categories like M&A, executive appointment, or compensation, the formation of a board committee with explicit oversight of strategic transformation, cost optimization, and capital allocation decisions would likely affect a reasonable investor's assessment of the company's strategic direction and financial priorities. This is material governance activity related to significant business strategy changes, but lacks the specificity of other event types.
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-06-08
Item 8.01
Cullinan Therapeutics announced initial Phase 1 clinical trial data for CLN-978 in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients from the OUTRACE trials, showing clinical activity with 71% of SLE patients achieving ≥4-point hSLEDAI reduction and 71% of RA patients demonstrating disease activity improvement, along with B cell depletion biomarker results. The data was presented at EULAR, a major rheumatology conference, and materially affects investor assessment of the company's pipeline development trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-08
Item 2.02
The filing discloses Duluth Holdings' financial results for its fiscal first quarter ended May 3, 2026, through an Earnings Press Release furnished as Exhibit 99.1. Item 2.02 explicitly covers "Results of Operations and Financial Conditions," and the prose confirms the Company issued a press release "discussing, among other things, its financial results for its fiscal first quarter." This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-08
Item 8.01
Palladyne AI entered into a Memorandum of Understanding with Israel Aerospace Industries granting exclusive manufacturing and marketing rights to loitering munitions systems (HAROP, HARPY, Mini-HARPY) for the U.S. government market, establishing a U.S. assembly line and multi-year commercial arrangement with defined royalty obligations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-08
Item 8.01
Ciena announced its intention to issue $2.0 billion of convertible senior notes due 2031 in a private placement under Rule 144A, with an additional $300 million option. The convertible notes are inherently dilutive securities that will convert to common stock, and the filing explicitly discloses concurrent warrant transactions relating to shares of common stock. This is a material capital-raising event typical of dilutive issuances at mid-cap technology companies.
View raw filing on EDGAR →